Appropriate blood provision for sickle cell disease patients in Northern Ireland

The appropriate selection of blood for transfusion in the ongoing treatment of patients with sickle cell disease is of vital importance. Here, Hannah Caldwell examines the role of sickle solubility testing and molecular genotyping in the care of SCD patients in Northern Ireland.

All together now: Summary of the 2022 Annual SHOT Report

The 2022 Annual Report from the Serious Hazards of Transfusion (SHOT) scheme has been published recently, once again collecting and analysing anonymised information on serious adverse events and reactions in blood transfusion from all healthcare organisations. Here SHOT Laboratory Incident Specialist Victoria Tuckley summarises its key points and recommendations.

Striving to improve transfusion safety: The 2021 SHOT Report

Nicola Swarbrick, Laboratory Incident Specialist at the Serious Hazards of Transfusion scheme, presents the key findings and recommendations from its 2021 report, which also marks 25 years since it was created to oversee and review haemovigilance reporting.

Incident investigation in blood transfusion practice: a review and update

In this article, Serious Hazards of Transfusion laboratory incident specialist Nicola Swarbrick focuses on a specific area of transfusion science haemovigilance practice – incident investigation – that was the topic of a SHOT webinar held last year.

Latest Issues